Nipah virus vaccine candidate Phase 1 clinical trial begins
by Press Release from Outbreak News Today on (#5VZGZ)
NewsDesk @bactiman63 Cambridge, Massachusetts company, Public Health Vaccines, LLC announced today the start of its Phase 1 clinical trial to evaluate the safety and immunogenicity of the company's single-dose vaccine (PHV02) against Nipah virus. The PHV02 vaccine is a live, attenuated, recombinant vesicular stomatitis virus (rVSV) vector that expresses the glycoprotein of the Nipah virus (Bangladesh [...]
The post Nipah virus vaccine candidate Phase 1 clinical trial begins appeared first on Outbreak News Today.